TOKYO -- Japan's Fujifilm Holdings will expand into the Chinese herbal medicine market through a partnership with China Resources (Holdings), a major state-run conglomerate in the world's second-largest economy.
The China Resources group manufactures and markets a range of herbal medicines as part of its vast business empire, which also includes China Resources Beer, hospital and other operations. By utilizing Fujifilm's technologies for extracting active ingredients and refining them for better body absorption, the duo aims to develop Chinese medicines that are more effective than traditional varieties. The fruits of their cooperation will be sold in China, Japan and elsewhere in Asia.
